← Leaderboards
Yuzuru Sasamoto
Brigham And Women'S Hospital
$2,923,308
Attributed
$2,923,308
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,923,308 · 4
By mechanism
R01$1,546,308 · 1
R00$689,117 · 1
R21$468,125 · 1
K99$219,758 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Edward P Ingenito$10,382,683
- Andrew Hoffman$2,294,927
- Natasha Y Frank$4,964,719
- Markus H. Frank$10,452,698
- Juliana Beverly Barrios$76,171
Others in their field
Other Emerging Leaders on “Corneal Epithelium”
- David Myung · Stanford University$3,424,155
- Han Peng · Northwestern University At Chicago$3,403,012
- Panteleimon Rompolas · University Of Pennsylvania$3,114,597
- Vivien Jane Coulson-Thomas · University Of Houston$2,939,260
- Heather Chandler · Ohio State University$2,907,094
- Yan Li · Oregon Health & Science University$2,457,725
Research focus
Corneal EpitheliumCorneaLimbalTissuesConjunctivaStem CellsMaintenancePhenotypeBlindnessCellsSingle-Cell Rna SequencingSuccessSignal PathwayAutologous TransplantationMolecularIn VitroHomologous TransplantationAreaFgfr2 GeneBilateralGenesRegulationStem Cell NicheCell Maintenance
Grant awards (9)
The role of BCAM-positive cells in central cornea, limbus and conjunctiva$793,119
R01 · FY2025 · EY · contact PI
The role of limbal fibroblasts for the maintenance of limbal stem cells$220,625
R21 · FY2025 · EY · contact PI
Development of cell-free approaches to the treatment of limbal stem cell deficiency$208,259
R00 · FY2025 · EY · contact PI
The role of BCAM-positive cells in central cornea, limbus and conjunctiva$753,189
R01 · FY2024 · EY · contact PI
The role of limbal fibroblasts for the maintenance of limbal stem cells$247,500
R21 · FY2024 · EY · contact PI
Development of cell-free approaches to the treatment of limbal stem cell deficiency$231,858
R00 · FY2024 · EY · contact PI
Development of cell-free approaches to the treatment of limbal stem cell deficiency$249,000
R00 · FY2023 · EY · contact PI
Development of cell-free approaches to the treatment of limbal stem cell deficiency$110,419
K99 · FY2021 · EY · contact PI
Development of cell-free approaches to the treatment of limbal stem cell deficiency$109,339
K99 · FY2020 · EY · contact PI